These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 28209754)
1. Myelodysplastic syndrome with excess blasts-2 associated with erythroid predominance. Pourabdollah M; Chang H Blood; 2017 Feb; 129(7):918. PubMed ID: 28209754 [No Abstract] [Full Text] [Related]
2. Erythroid proliferations in myeloid neoplasms. Wang SA; Hasserjian RP Hum Pathol; 2012 Feb; 43(2):153-64. PubMed ID: 22154053 [TBL] [Abstract][Full Text] [Related]
3. Acute myeloid leukaemia and myelodysplastic syndromes with 50% or greater erythroblasts: a diagnostic conundrum. Wong E; Juneja S Pathology; 2015 Jun; 47(4):289-93. PubMed ID: 25938365 [TBL] [Abstract][Full Text] [Related]
4. Pure erythroid leukemia: a reassessment of the entity using the 2008 World Health Organization classification. Liu W; Hasserjian RP; Hu Y; Zhang L; Miranda RN; Medeiros LJ; Wang SA Mod Pathol; 2011 Mar; 24(3):375-83. PubMed ID: 21102413 [TBL] [Abstract][Full Text] [Related]
5. Erythroleukemia shares biological features and outcome with myelodysplastic syndromes with excess blasts: a rationale for its inclusion into future classifications of myelodysplastic syndromes. Calvo X; Arenillas L; Luño E; Senent L; Arnan M; Ramos F; Ardanaz MT; Pedro C; Tormo M; Montoro J; Díez-Campelo M; Arrizabalaga B; Xicoy B; Bonanad S; Jerez A; Nomdedeu B; Ferrer A; Sanz GF; Florensa L Mod Pathol; 2016 Dec; 29(12):1541-1551. PubMed ID: 27562492 [TBL] [Abstract][Full Text] [Related]
6. The effects of azacitidine on the response and prognosis of myelodysplastic syndrome and acute myeloid leukemia involving a bone marrow erythroblast frequency of >50. Uchida T; Hagihara M; Hua J; Inoue M Leuk Res; 2017 Feb; 53():35-38. PubMed ID: 28013105 [TBL] [Abstract][Full Text] [Related]
7. Considering Bone Marrow Blasts From Nonerythroid Cellularity Improves the Prognostic Evaluation of Myelodysplastic Syndromes. Arenillas L; Calvo X; Luño E; Senent L; Alonso E; Ramos F; Ardanaz MT; Pedro C; Tormo M; Marco V; Montoro J; Díez-Campelo M; Brunet S; Arrizabalaga B; Xicoy B; Andreu R; Bonanad S; Jerez A; Nomdedeu B; Ferrer A; Sanz GF; Florensa L J Clin Oncol; 2016 Sep; 34(27):3284-92. PubMed ID: 27382099 [TBL] [Abstract][Full Text] [Related]
8. Identification and quantitation of blasts in myeloid malignancies with marrow fibrosis or marrow hypoplasia and CD34 negativity. Nedumannil R; Sim S; Westerman D; Juneja S Pathology; 2021 Oct; 53(6):795-798. PubMed ID: 33612271 [No Abstract] [Full Text] [Related]
9. Marked erythropoietin-induced dysplastic erythropoiesis in a patient with myelodysplastic syndrome. Narukawa K; Masuda A; Takahashi T Int J Hematol; 2021 Jun; 113(6):775-776. PubMed ID: 33864622 [No Abstract] [Full Text] [Related]
10. Reproducibility of the World Health Organization 2008 criteria for myelodysplastic syndromes. Senent L; Arenillas L; Luño E; Ruiz JC; Sanz G; Florensa L Haematologica; 2013 Apr; 98(4):568-75. PubMed ID: 23065505 [TBL] [Abstract][Full Text] [Related]
11. Does a diagnosis of myelogenous leukemia require 20% marrow myeloblasts, and does <5% marrow myeloblasts represent a remission? The history and ambiguity of arbitrary diagnostic boundaries in the understanding of myelodysplasia. Lichtman MA Oncologist; 2013; 18(9):973-80. PubMed ID: 23982763 [TBL] [Abstract][Full Text] [Related]
12. The myelodysplastic syndromes. Part I. What are they? Part II. Classification. Galton DA Scand J Haematol Suppl; 1986; 45():11-20. PubMed ID: 3515515 [No Abstract] [Full Text] [Related]
13. Histopathology in the diagnosis of high-risk myelodysplastic syndromes. Kayano H J Clin Exp Hematop; 2018; 58(2):51-60. PubMed ID: 29998976 [TBL] [Abstract][Full Text] [Related]
14. Acute erythroid neoplastic proliferations. A biological study based on 62 patients. Domingo-Claros A; Larriba I; Rozman M; Irriguible D; Vallespí T; Aventin A; Ayats R; Millá F; Solé F; Florensa L; Gallart M; Tuset E; Lopez C; Woessner S Haematologica; 2002 Feb; 87(2):148-53. PubMed ID: 11836165 [TBL] [Abstract][Full Text] [Related]
15. Pure erythroid leukemia. Wang W; Wang SA; Medeiros LJ; Khoury JD Am J Hematol; 2017 Mar; 92(3):292-296. PubMed ID: 28006859 [TBL] [Abstract][Full Text] [Related]
16. [How to differentiate myelogenous leukemia FAB-type 6 (erythroleukemia) from the myelodysplastic syndrome?]. Stavem P; Evensen SA; Brinch L; Strømsheim JP Tidsskr Nor Laegeforen; 1992 Aug; 112(19):2557-8. PubMed ID: 1412272 [No Abstract] [Full Text] [Related]
17. Epitaph for erythroleukemia. Zini G; d'Onofrio G Haematologica; 2004 Aug; 89(8):ELT11. PubMed ID: 15339700 [No Abstract] [Full Text] [Related]
18. Acute erythroid leukemia with <20% bone marrow blasts is clinically and biologically similar to myelodysplastic syndrome with excess blasts. Wang SA; Patel KP; Pozdnyakova O; Peng J; Zuo Z; Dal Cin P; Steensma DP; Hasserjian RP Mod Pathol; 2016 Oct; 29(10):1221-31. PubMed ID: 27443511 [TBL] [Abstract][Full Text] [Related]
19. Myelodysplastic syndrome with clonal cytogenetic abnormalities followed by fatal erythroid leukemia after 14 years of exposure to hydroxyurea for sickle cell anemia. Aumont C; Driss F; Lazure T; Picard V; Creidy R; De Botton S; Saada V; Lambotte O; Bilhou-Nabera C; Tertian G; Michot JM Am J Hematol; 2015 Jul; 90(7):E131-2. PubMed ID: 25801602 [No Abstract] [Full Text] [Related]
20. Immature erythroblasts in pleural effusion: an initial presentation of acute erythroid leukemia in a patient with a history of MDS. Hu Z; Ok CY Blood; 2024 Aug; 144(7):794. PubMed ID: 39145944 [No Abstract] [Full Text] [Related] [Next] [New Search]